PROGRAM OVERVIEW
This enduring activity will cover the care and treatment of patients with moderate-to-severe atopic dermatitis.
TARGET AUDIENCE
This enduring activity is intended for dermatologists, allergists, advanced practitioners, and other health care professionals involved in the care and treatment of patients with moderate-to-severe atopic dermatitis.
LEARNING OBJECTIVES
On completing the program, attendees should be able to:
- Identify patients with moderate-to-severe atopic dermatitis (AD) who may benefit from systemic therapy
- Evaluate clinical trial data on the efficacy and safety of available and emerging JAK inhibitors for treating AD
- Develop individualized treatment plans for adolescent and adult patients with AD who require treatment intensification
- Recognize and manage adverse events associated with JAK inhibitors in managing AD
ACCREDITATION AND DESIGNATION STATEMENTS
PHYSICIAN
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES
This program would be beneficial for nurses involved in treating and managing patients with moderate-to-severe atopic dermatitis.
CNE Credits:
1.0 ANCC Contact Hour
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
FACULTY
Peter Lio, MD (Program Chair)
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois
DISCLOSURE OF UNLABELED USE
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
SPEAKER | RELATIONSHIP | MANUFACTURER |
---|---|---|
Peter A. Lio, MD (Program Chair) |
Consultant | Dermavant Sciences, Galderma, Pierre-Fabre, Level Ex, UCB, Regeneron/Sanofi Genzyme, Pfizer, Micreos, Johnson and Johnson, Menlo Therapeutics, IntraDerm, AOBiome, Realm Therapeutics, Altus Labs, Verrica, Arbonne, Bodewell, YobeeCare, My-Or Diagnostics, Kimberly-Clark |
Speaker | Unilever, Arbonne, Verrica, Burt’s Bees, Galderma, Eli Lilly and Company, L’Oreal USA Inc. | |
Advisory Board | Dermira, Pfizer, LEO Pharmaceuticals, AbbVie, Eli Lilly and Company, L’Oreal USA Inc., Pierre-Fabre, Level Ex, Unilever, Theraplex, Exeltis, AOBiome, Galderma, Amyris, Bodewell, YobeeCare, Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark | |
Research | National Eczema Association, AOBiome, Regeneron/Sanofi Genzyme, AbbVie | |
Patent Holder | Theraplex | |
Stockholder | Micreos, YobeeCare, and Altus Labs |
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Planners
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Marcello Morgan, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing
Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing
Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating in and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Complete pre and post survey.
- Submit the evaluation form online.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making experience before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.